TOG Review (RCOG Journal)

MRCOG Part 2

Antenatal Care

The management of chronic pain in pregnancy

Key Statistics

  • >3 months — Defines chronic pain
  • up to 28% — Pregnant women with pre-existing chronic pain
  • 55–94% — Neonatal abstinence syndrome after antenatal opioids

Don't-miss facts

  1. NSAIDs only before 28 weeks, shortest course — late use risks oligohydramnios (5×) and ductus arteriosus constriction (0.5%). Analgesic aspirin >300 mg/day in late pregnancy not advised

  2. NAS in 55–94% of opioid-exposed newborns — involve neonatology early; NICE prefers replacement over detoxification; breastfeeding reduces need for withdrawal treatment

  3. Codeine avoided in breastfeeding (CYP2D6 ultra-rapid metabolisers) — use dihydrocodeine. Ibuprofen/diclofenac are the postnatal NSAIDs of choice

  4. Serotonergic drugs → PPH RR 1.32 (SNRI 1.79); ~34% vs 26% background — active management of the third stage; no excess risk if stopped ≥1 month before birth

  5. Late SSRI: neonatal adaptation syndrome ~30% (background 10%); persistent pulmonary hypertension of the newborn ~2/1000 (background 3/1000)

  6. Valproate = major teratogen; carbamazepine → dose-dependent neural tube defects; lamotrigine/levetiracetam = background 2–3%. Folic acid for all + ultrasound screening essential

  7. Headache in pregnancy: exclude pre-eclampsia and cerebral venous thrombosis. Sumatriptan safe; propranolol preferred prophylaxis; no opioids for migraine/tension/cluster headache

  8. Sacral nerve stimulators must not be placed or used in pregnancy; invasive neuromodulation not recommended — contact the implanting service early (spinal anaesthesia for caesarean may still be possible)

Framework

Chronic pain >3 months; up to 28% of pregnant women have a pre-existing condition; WHO ladder does not apply Classify: primary vs secondary (ICD-11) and nociceptive / neuropathic / nociplastic No pregnancy-specific chronic pain guideline; NICE NG193 omits pregnancy. Non-specialists should not initiate treatment — refer to a specialist/ad hoc MDT (maternal medicine, pain physician, neonatologist, physiotherapist, psychologist) Try non-pharmacological first; anticipate higher peripartum analgesic requirements — early anaesthetic input

Drugs at a glance

Paracetamol — safe, pregnancy & breastfeeding Sumatriptan — safe

Amitriptyline — 1st choice neuropathic pain in pregnancy NSAIDs — only <28 weeks, short course

Gabapentinoids — specialist, neonatal withdrawal Sodium valproate — major teratogen Codeine — not in breastfeeding

Intravesical dimethyl sulfoxide — teratogenic (animal)

Guideline map

NICE NG193 chronic primary pain · NG59 low back pain · CG173 neuropathic pain · CG150 headaches RCOG GTG 70 bladder pain syndrome · GTG 41 chronic pelvic pain · SIP 59 antenatal/postnatal analgesia RCP fibromyalgia (2022) and CRPS (2018) · resources: UKTIS, BUMPS, LactMed, BPS PMP directory NICE recommends CBT/ACT, exercise, acupuncture; PMPs endorsed by FPM/BPS but not by NICE; TENS not recommended for chronic pain

Abbreviation Key

  • ACT — acceptance and commitment therapy
  • ICD-11 — International Classification of Diseases, 11th revision
  • ADHD — attention deficit hyperactivity disorder
  • LactMed — Drugs and Lactation Database
  • AED — antiepileptic drug
  • MHRA — Medicines and Healthcare products Regulatory Agency
  • aOR / aRR — adjusted odds ratio / adjusted relative risk
  • NAS — neonatal abstinence syndrome
  • BPS — British Pain Society
  • NICE — National Institute for Health and Care Excellence
  • BUMPS — Best Use of Medicines in Pregnancy
  • NSAID — non-steroidal anti-inflammatory drug
  • CBT — cognitive behavioural therapy
  • OR / RR — odds ratio / relative risk
  • CLBP — chronic low back pain
  • PMP — pain management programme
  • COX — cyclooxygenase
  • PPH — postpartum haemorrhage
  • CRPS — complex regional pain syndrome
  • SNRI — serotonin–noradrenaline reuptake inhibitor
  • CYP2D6 — cytochrome P450 2D6 enzyme
  • SSRI — selective serotonin reuptake inhibitor
  • FPM — Faculty of Pain Medicine
  • TENS — transcutaneous electrical nerve stimulation
  • HR — hazard ratio
  • UKTIS — UK Teratology Information Service
  • IASP — International Association for the Study of Pain
  • WHO — World Health Organization

Source: Hutchinson L, Petrosellini C, McGuckin D et al. The management of chronic pain in pregnancy. The Obstetrician & Gynaecologist 2026;28:16–29. doi:10.1111/tog.70025

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free